澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ORTHOCELL LTD

0.995

+0.0606.42%

成交量：50.61万

成交额：49.42万

市值：2.70亿

市盈率：-25.93

高：0.995

开：0.950

低：0.940

收：0.935

52周最高：1.730

52周最低：0.855

股本：2.71亿

流通股本：1.94亿

量比：1.95

换手率：0.26%

股息：- -

股息率：- -

每股收益(TTM):-0.038

每股收益(LYR):-0.038

净资产收益率：-89.70%

总资产收益率：-26.42%

市净率：18.51

市盈率(LYR):-25.93

数据加载中...

总览公司新闻资讯公告

概念

医药生物股+1.83%

资金流向

资金流入：

资金流出：

新闻资讯

Orthocell Ltd 增持Marine Biomedical股权至11.7%，总投资额达105万澳元

ORTHOCELL LTD - 提交监管申请以在欧盟和英国神经修复市场上商业分销Remplir

上届喊单王 Murad：2026 年牛市会来的 116 个理由

Orthocell Ltd 增加对 Marine Biomedical 的股权至 12.0%，总代价为 100 万澳元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/OCC.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","market":"AU","secType":"STK","nameCN":"ORTHOCELL LTD","latestPrice":0.995,"timestamp":1770693666265,"preClose":0.935,"halted":0,"volume":506140,"delay":0,"changeRate":0.06417112299465234,"nameEN":"ORTHOCELL LTD","floatShares":194076512,"shares":271090199,"eps":-0.03837,"marketStatus":"交易中","change":0.06,"latestTime":"02-10 14:21:34 AEDT","open":0.95,"high":0.995,"low":0.94,"amount":494183,"amplitude":0.058824,"askPrice":1,"askSize":17048,"bidPrice":0.995,"bidSize":44181,"shortable":3,"etf":0,"ttmEps":-0.03837,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.935,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.951611,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","floatShares":194076512,"roa":"-26.42%","roe":"-89.70%","lyrEps":-0.03837,"volumeRatio":1.951611,"shares":271090199,"dividePrice":0,"high":0.995,"amplitude":0.058824,"preClose":0.935,"low":0.94,"week52Low":0.855,"pbRate":"18.51","psRate":"35.72","week52High":1.73,"institutionHeld":0,"latestPrice":0.995,"committee":0.44314,"eps":-0.03837,"divideRate":0,"volume":506140,"delay":0,"ttmEps":-0.03837,"open":0.95,"prevYearClose":1.085,"prevWeekClose":0.91,"prevMonthClose":0.92,"prevQuarterClose":1.085,"fiveDayClose":0.955,"twentyDayClose":1.06,"sixtyDayClose":1.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCC.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150494114","title":"Orthocell Ltd 增持Marine Biomedical股权至11.7%，总投资额达105万澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150494114","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150494114?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 06:05","pubTimestamp":1768514717,"startTime":"0","endTime":"0","summary":"再生医学公司Orthocell Ltd宣布，已将其在海洋生物医药公司Marine Biomedical的持股比例提升至11.7%。此次增持使Orthocell对该公司的累计投资总额达到105万澳元。该举措进一步深化了双方在创新生物医学领域的战略合作，有望为Orthocell的产品管线注入新的技术资源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","OCC.AU","BK7508"],"gpt_icon":0},{"id":"1129794615","title":"ORTHOCELL LTD - 提交监管申请以在欧盟和英国神经修复市场上商业分销Remplir","url":"https://stock-news.laohu8.com/highlight/detail?id=1129794615","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129794615?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 06:07","pubTimestamp":1765750031,"startTime":"0","endTime":"0","summary":"ORTHOCELL LTD - 提交监管申请以在欧盟和英国神经修复市场上商业分销Remplir","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OCC.AU","BK7067"],"gpt_icon":0},{"id":"2588951833","title":"上届喊单王 Murad：2026 年牛市会来的 116 个理由","url":"https://stock-news.laohu8.com/highlight/detail?id=2588951833","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588951833?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 23:00","pubTimestamp":1764860416,"startTime":"0","endTime":"0","summary":" “我并不认同市场周期仅为四年的观点，我认为这一周期可能会延长至四年半甚至五年，并可能持续到 2026 年。” ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2226389","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETH","OI","BTC","09042","03008","03042","BK4594","BK4550","BK7067","BK4126","BTC.USD.HKCC","OCC","09008","BK4020","BK4585","OCC.AU","FDN","BK4588","03439","09439","BK1611","MBTmain","BTC.USD.CC","83042","BK7508","BK4601"],"gpt_icon":1},{"id":"1149412243","title":"Orthocell Ltd 增加对 Marine Biomedical 的股权至 12.0%，总代价为 100 万澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149412243","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149412243?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 05:59","pubTimestamp":1760911141,"startTime":"0","endTime":"0","summary":"Orthocell Ltd 增加对 Marine Biomedical 的股权至 12.0%，总代价为 100 万澳元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCC.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OCC.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"医药生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.018266}]}}